p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by α-Interferon

We have determined how the phosphorylation of the retinoblastoma family (pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B-cells during cell cycle exit triggered by α-interferon (α-IFN). α-IFN causes dephosphorylation of pRb and loss of p130 phosphorylated Form 3. Howeve...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 273; no. 37; p. 23659
Main Authors Nicholas S. B. Thomas, Arnold R. Pizzey, Sanjay Tiwari, Catherine D. Williams, Jiewu Yang
Format Journal Article
LanguageEnglish
Published American Society for Biochemistry and Molecular Biology 11.09.1998
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have determined how the phosphorylation of the retinoblastoma family (pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B-cells during cell cycle exit triggered by α-interferon (α-IFN). α-IFN causes dephosphorylation of pRb and loss of p130 phosphorylated Form 3. However, the change in p130 phosphorylation in response to α-IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G 1 , whereas pRb is dephosphorylated only in G 1 . In contrast, p107 is dephosphorylated and is then depleted from cells as they exit the cell cycle. p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F-4, whereas pRb binds both E2F-4 and E2F-1. The phosphorylated forms of E2F-4 that bind to the E2F DNA site are different from hyperphosphorylated E2F-4, which predominates in primary hemopoietic cells in G 0 . We conclude that although cell cycle arrest induced by α-IFN may be mediated in part by formation of a complex containing p130 and E2F-4, α-IFN does not induce hyperphosphorylation of E2F-4, which characterizes primary hemopoietic cells in G 0 .
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.273.37.23659